[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-LXEO":3,"homepage-market-summary":30,"stock-news-LXEO":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"LXEO","2026-10-06",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Lexeo Therapeutics, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.","59","New York, NY",false,{"close":16,"open":17,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},3.3,3.43,3.17,3.41,-0.11,-3.23,1535334.301218,13610,3.3045,10.99,2.98,1134120.467550881,4,732,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":153},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51521,253,0.49,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":14,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",239.24,0.34,0.14,"0.0,14.1 7.3,16.0 14.7,14.6 22.0,11.8 29.3,8.2 36.7,2.4 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.63,0.74,0.22,"0.0,2.0 7.3,16.0 14.7,10.4 22.0,14.6 29.3,9.3 36.7,10.6 44.0,9.4",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",380.68,1.95,0.51,"0.0,13.7 7.3,16.0 14.7,15.0 22.0,15.4 29.3,7.1 36.7,3.0 44.0,2.0",[99,104,109,114,119,124,129,134,139,144,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",0.53,202,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.24,54.01,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.17,167.09,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.2,111.75,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.9,81.77,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.47,63.75,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.87,171.58,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.46,49.73,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",1.06,41.1,{"name":145,"etf":146,"change":26,"price":147,"is_up":39},"Utilities","XLU",41.16,{"name":149,"etf":150,"change":151,"price":152,"is_up":39},"Comm Services","XLC",0.04,111.65,[154,159,163,167],{"ticker":155,"name":156,"price":157,"change":158,"is_up":39},"SPY","SPDR S&P 500 ETF",779.09,0.55,{"ticker":160,"name":161,"price":162,"change":137,"is_up":39},"QQQ","Invesco QQQ Trust",759.69,{"ticker":164,"name":165,"price":166,"change":46,"is_up":39},"DIA","SPDR Dow Jones ETF",514.56,{"ticker":168,"name":169,"price":170,"change":171,"is_up":14},"IWM","iShares Russell 2000",281.37,-0.71,{"ticker":4,"count":173,"articles":174},10,[175,181,187,192,198,203,208,212,217,222],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"$LXEO stock is down 14% today. Here's what we see in our data. - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxPN282VmYzN29EaTZUenBIZVRVT2szOVd4N2NNcFdhMWFfbEJLWDhhR1ktaGJwVnZJUS01cVZkamtaMHdOZHV5anl1QUhrS1l6RnJFZGVyQTBJWFVRaWM4dVRoUUxSa0FYTUo0MUhDRVhzQnRFd05nbF9QY2UwdmpXVi1JSjR0S3h4UTBDSDVTRXhjbFpmMzZwbUZ3Zk5WQ19hMVE?oc=5","Wed, 23 Sep 2026 19:18:00 GMT","$LXEO stock is down 14% today. Here's what we see in our data. Quiver Quantitative","Quiver Quantitative",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"A virtual heart-and-metabolism forum will include Lexeo on Sept. 30. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxPNFU3LXVmRzNaTWdLRWtfTWl4d2JlZ3p0YW04cTF3aUNsMHpzT3U0dzF3bF9SVDY5dEFIa1g2SnFpUW02OXQtMUNDczYzUnpiU3gwbWJ4RWY5Ykdsa3lMcE5vYVJJX2RMTWE3QkNLMkEtaHdKcU4zM3pjVzN2MjdLYjhld3dmNVU4MjdoOElnaFpqWHROU1Z6SE5wMnRQR1hCdUp3akUyUzhuQ3VTcWdnaHE5N0FIUQ?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","A virtual heart-and-metabolism forum will include Lexeo on Sept. 30. Stock Titan","Stock Titan",{"title":188,"link":189,"pubDate":190,"description":191,"source":186},"Early data found stable or improved neurologic scores among gene therapy participants. New analyses are due Oct. 7. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxQeU1vQ0ZUbnNyR3ZILTB0UjFZa0RWUG9KcEtQT0Rfd0JNTC1BUlVoZ1QteTR6WWIxZ1RnN0lrU2xSenlsVDBxcmtmdE9LSTJsZUFVQ055U05Jb3Atck9FVmp1S1hzZlRVYk1IbS1YdFVXRkVrdFlGdXRvSUVzb0tHeENsUUoxNFZxSGJxRTJ1UFhFVFJSNkpjbDFNSkZiZFlvX1V1Tks1b1hYdkxGalZFQXhuV0hyVW9uVEE?oc=5","Thu, 01 Oct 2026 13:00:00 GMT","Early data found stable or improved neurologic scores among gene therapy participants. New analyses are due Oct. 7. Stock Titan",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"Stifel reiterates Buy rating on Lexeo Therapeutics stock at $17 - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxNVlVrejZZeHF5bWxtdUNqWnFOd1E4RWlkX0JzZnJYcThseE9Qa1BtSHRDR1lyc3JuV0NTRVI2RUt0dEE4U1hDdFd1Uk40X1Y1SjRZbUphWFpibXpqb2RmeTZpeXVBNldpcGNPM1daWFdrS2pRclJWU1Zudmt5eG5uQW9nZkh0bnhnczF3dTk5aWhGbUpIamc5cWdtTXFwU3pZQTk3ZWdUUTY1Q0otUy1teGFUcmM2eUtTdDBQTnI1aw?oc=5","Mon, 05 Oct 2026 10:27:49 GMT","Stifel reiterates Buy rating on Lexeo Therapeutics stock at $17 Investing.com","Investing.com",{"title":199,"link":200,"pubDate":184,"description":201,"source":202},"Leerink Partners maintains Outperform rating on Lexeo Therapeutics, $15 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3AFBVV95cUxPcHpHTFVtLTVFR2RxTnJFSXdTQnpMbzM3ODdudXBBY3ZQbTJuYXpPd1JZUnl6VVo3bWk3bGNwTnZ6WmN6SWdpb3ZiRHctbHlERldGYXlzRWZTT3BnZlk0VlNhcEMtOWxLYU5tZ3p0SThSSDNsSVUzMzZlMHZneHNXUXhUdmxvcUJMbGprZDhrVnlhS20tQ0Z4SndiajZ0M2hwT0FVcjgtR0pHN3Noc2sxQTlvejYxMVVXZWZiTGVsT2ZYRW9VQjdnNjV1aDJMcEgtYUZBd1lvazFPVE5M?oc=5","Leerink Partners maintains Outperform rating on Lexeo Therapeutics, $15 price target TradingView","TradingView",{"title":204,"link":205,"pubDate":206,"description":207,"source":186},"Lexeo Therapeutics (LXEO) awards its COO an option covering 54,750 shares - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxORno0MjZlWm1BV2dKRElhenNSZ001LXJCTkJpRnZURVdrSjF0Y2VHY0tjNWdxWG5KT0V2NHZ5bjZzSHNjVUZrQldaaHB2SmdBZFhrOEhVZ3BXOE1OTVJyYVFsRWpTSWNsaF9zT1ZhWVA5aEFsUmhwYk93N2NoNUlDY2VGZXlsWmdmV3ZhUlV1VEJjc1o1dTdIdFM3N2tkTkxqdUhKVEVJSFpjLVVWWnZZYkZqNXRSSHc?oc=5","Mon, 28 Sep 2026 21:15:43 GMT","Lexeo Therapeutics (LXEO) awards its COO an option covering 54,750 shares Stock Titan",{"title":209,"link":210,"pubDate":206,"description":211,"source":186},"At $3.39 a share, Lexeo Therapeutics (LXEO) grants its CFO 54,750 stock options. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxOdHJlTTRmUG5HSHowMFJrdzJjelg0U2EzRFpoOTlaXzczZkwtR1BoelA5Qm5EU1VLTDNpTF91bEtFTi02OHd1VWJfNDhQNDRTUU1kc1VKVFhCSURoOGRXaEZEQlZZTTVsTGM3V2lRME5tQjhxSWM3OWtUVVBjRDdNTk01My1pLXBxOVE0aDZHN09uU3UyXzRrMGNxMGNMWEZMcDJaWE95Z3c3anZkeUZET1Q2TTdWSjg?oc=5","At $3.39 a share, Lexeo Therapeutics (LXEO) grants its CFO 54,750 stock options. Stock Titan",{"title":213,"link":214,"pubDate":215,"description":216,"source":197},"Lexeo Therapeutics completes acquisition of Mantle Therapeutics - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxNd2syZC1IdHBwTlJhSS1WVUJqQ1dWbU9Gb1U0eGxVZ0Z2UFVISnRPVDJLem9nbzU0V1AwRER3TEJLbEhIRXhSM1lhR25CS29oRmZINWx2N3RibGpudUFrT1RUNEt4UmhuSDhUa3k5ZTN3Tl8tR2VlQmVvRGR3TjRDNGREUF9ldEFUMHJwZExSNEw5Q1NtNmxUZkYtYXBsR3dNNnd4RnhCTk5aUUU2VXhWTzF4bzRuSjJyMm9R?oc=5","Tue, 29 Sep 2026 21:20:06 GMT","Lexeo Therapeutics completes acquisition of Mantle Therapeutics Investing.com",{"title":218,"link":219,"pubDate":220,"description":221,"source":186},"Lexeo Therapeutics (LXEO) medical chief acquires 2,714 shares through an employee plan - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxQMEpFbk1xdVF5ZERFUXRETmJaSjJGMEJVQjJULWljdzZUbWxWWHJmZ1d0WW9CYXJDNGpFLWt4X3lIZEFaYUNFRDZCcmNua2VQY0J3eGphOWptZi02b2VFT1dKOFA2WjYxU0JWMHowSjloazJjeTJvZk1Jb01RTFR2ZV83VkMwX1ZMSHhpWHhqRVNVaXAxclhKcUpMdW1Yb09DaE13enBXUEZXajRUeGZNSWctSnE3Sk0?oc=5","Mon, 28 Sep 2026 21:15:50 GMT","Lexeo Therapeutics (LXEO) medical chief acquires 2,714 shares through an employee plan Stock Titan",{"title":223,"link":224,"pubDate":225,"description":226,"source":186},"Lexeo Therapeutics (LXEO) CEO acquires 2,306 shares through an employee plan and receives a stock option. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxPQXprbVBfWndYR0tXOWZXdTBwc19XeGJIMDkxMkJvTW9pTVBFa0Vsay1jZFNULVNzOHJTSDZFcGdjX2FYTmt2RjlfQ2thQjRsaHhDYXBaY1ZuRXB3cWoxY3J5LVJHYlZJMVVqZm9SRHFrMVlQdkE2RUdXX0lTdjh4ZkRGVkVpUktkMEpiN1RMV19hTGZVbjNMM2Zxdmc4OXVocFRDQTN0TzBzRVFzbnBLRVBEUkNMdmM?oc=5","Mon, 28 Sep 2026 21:15:42 GMT","Lexeo Therapeutics (LXEO) CEO acquires 2,306 shares through an employee plan and receives a stock option. Stock Titan"]